Regulatory T cell-mediated suppression: Potential role of ICER

Journal of Leukocyte Biology

Volumn 81, Issue 1, 2007, Pages 161-167

  Bodor, Josef ^a   Fehervari, Zoltan ^b   Diamond, Betty ^a   Sakaguchi, Shimon ^c  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Immune regulation; Inhibitory receptor; Transcriptional repressor

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HISTONE ACETYLTRANSFERASE PCAF; INTERLEUKIN 10; INTERLEUKIN 2; LIGAND; PROTEIN INDUCIBLE CAMP EARLY REPRESSOR; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CD25+ T LYMPHOCYTE; CELL CONTACT; CELL FUNCTION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CYCLIC AMP RESPONSE ELEMENT MODULATOR; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2; MEMBRANE PROTEINS; MICE; MODELS, IMMUNOLOGICAL; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845904901     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0706474     Document Type: Review

References (82)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
2. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., Nomura, T. (2006) Foxp3CD25CD4 natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27.
3. Kyewski, B., Klein, L. (2006) A central role for central tolerance. Annu. Rev. Immunol. 24, 571-606.
4. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., Levings, M. K. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50.
5. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., Sakaguchi, S. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980.
6. Thornton, A. M., Shevach, E. M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296.
7. Dieckmann, D., Bruett, C. H., Ploettner, H., Lutz, M. B., Schuler, G. (2002) Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196, 247-253.
8. Jonuleit, H., Schmitt, E., Kakirman, H., Stassen, M., Knop, J., Enk, A. H. (2002) Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196, 255-260.
9. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., Sakaguchi, S. (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
10. Read, S., Malmstrom, V., Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302.
11. Nakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H., Strober, W. (2004) TGF-β 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 172, 834-842.
12. Nakamura, K., Kitani, A., Strober, W. (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644.
13. McGuirk, P., McCann, C., Mills, K. H. (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231.
14. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G., Wahl, S. M. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886.
15. Fehervari, Z., Yamaguchi, T., Sakaguchi, S. (2006) The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol. 27, 109-111.
16. Hori, S., Nomura, T., Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
17. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., Rudensky, A. Y. (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151.
18. Knoechel, B., Lohr, J., Kahn, E., Bluestone, J. A., Abbas, A. K. (2005) Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202, 1375-1386.
19. Thornton, A. M., Donovan, E. E., Piccirillo, C. A., Shevach, E. M. (2004) Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172, 6519-6523.
20. Greenwald, R. J., Freeman, G. J., Sharpe, A. H. (2005) The B7 family revisited. Annu. Rev. Immunol. 23, 515-548.
21. Wing, K., Lindgren, S., Kollberg, G., Lundgren, A., Harris, R. A., Rudin, A., Lundin, S., Suri-Payer, E. (2003) CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur. J. Immunol. 33, 579-587.
22. Teft, W. A., Kirchhof, M. G., Madrenas, J. (2006) A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24, 65-97.
23. Collins, A. V., Brodie, D. W., Gilbert, R. J., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., Davis, S. J. (2002) The interaction properties of costimulatory molecules revisited. Immunity 17, 201-210.
24. Stamper, C. C., Zhang, Y., Tobin, J. F., Erbe, D. V., Ikemizu, S., Davis, S. J., Stahl, M. L., Seehra, J., Somers, W. S., Mosyak, L. (2001) Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410, 608-611.
25. Pentcheva-Hoang, T., Egen, J. G., Wojnoonski, K., Allison, J. P. (2004) B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21, 401-413.
26. Vendetti, S., Riccomi, A., Sacchi, A., Gatta, L., Pioli, C., De Magistris, M. T. (2002) Cyclic adenosine 5′-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4+ T lymphocytes. J. Immunol. 169, 6231-6235.
27. Hansen, W., Loser, K., Westendorf, A. M., Bruder, D., Pfoertner, S., Siewert, C., Huehn, J., Beissert, S., Buer, J. (2006) G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J. Immunol. 177, 209-215.
28. Sugimoto, N., Oida, T., Hirota, K., Nakamura, K., Nomura, T., Uchiyama, T., Sakaguchi, S. (2006) Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18, 1197-1209.
29. Baratelli, F., Lin, Y., Zhu, L., Yang, S. C., Heuze-Vourc'h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S., Dubinett, S. M. (2005) Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175, 1483-1490.
30. Mahic, M., Yaqub, S., Johansson, C. C., Tasken, K., Aandahl, E. M. (2006) FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 177, 246-254.
31. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M. L., Puccetti, P. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206-1212.
32. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
33. Taylor, P. A., Lees, C. J., Fournier, S., Allison, J. P., Sharpe, A. H., Blazar, B. R. (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172, 34-39.
34. Paust, S., Cantor, H. (2005) Regulatory T cells and autoimmune disease. Immunol. Rev. 204, 195-207.
35. Paust, S., Lu, L., McCarty, N., Cantor, H. (2004) Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101, 10398-10403.
36. Peggs, K. S., Quezada, S. A., Korman, A. J., Allison, J. P. (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr. Opin. Immunol. 18, 206-213.
37. Bodor, J., Fehervari, Z., Sakaguchi, S. (2006) Transcriptional attenuation of IL-2 and potential rule of ICER/CREM in suppression by regulatory T cells. Submitted.
38. Molina, C. A., Foulkes, N. S., Lalli, E., Sassone-Corsi, P. (1993) Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75, 875-886.
39. Bodor, J., Spetz, A. L., Strominger, J. L., Habener, J. F. (1996) cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc. Natl. Acad. Sci. USA 93, 3536-3541.
40. Tenbrock, K., Juang, Y. T., Gourley, M. F., Nambiar, M. P., Tsokos, G. C. (2002) Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J. Immunol. 169, 4147-4152.
41. Powell, J. D., Lerner, C. G., Ewoldt, G. R., Schwartz, R. H. (1999) The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163, 6631-6639.
42. Krummel, M. F., Allison, J. P. (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
43. Schneider, H., Mandelbrot, D. A., Greenwald, R. J., Ng, F., Lechler, R., Sharpe, A. H., Rudd, C. E. (2002) Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand- deficient mice. J. Immunol. 169, 3475-3479.
44. Yehia, G., Schlotter, F., Razavi, R., Alessandrini, A., Molina, C. A. (2001) Mitogen-activated protein kinase phosphorylates and targets inducible cAMP early repressor to ubiquitin-mediated destruction. J. Biol. Chem. 276, 35272-35279.
45. Folco, E. J., Koren, G. (1997) Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem. J. 328, 37-43.
46. Furtado, G. C., Curotto de Lafaille, M. A., Kutchukhidze, N., Lafaille, J. J. (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196, 851-857.
47. Malek, T. R., Bayer, A. L. (2004) Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4, 665-674.
48. Tarbell, K. V., Yamazaki, S., Steinman, R. M. (2006) The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin. Immunol. 18, 93-102.
49. Thornton, A. M., Piccirillo, C. A., Shevach, E. M. (2004) Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur. J. Immunol. 34, 366-376.
50. Tang, Q., Boden, E. K., Henriksen, K. J., Bour-Jordan, H., Bi, M., Bluestone, J. A. (2004) Distinct roles of CTLA-4 and TGF-β in CD4(+)CD25(+) regulatory T cell function. Eur. J. Immunol. 34, 2996-3005.
51. Zheng, S. G., Wang, J. H., Stohl, W., Kim, K. S., Gray, J. D., Horwitz, D. A. (2006) TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 176, 3321-3329.
52. Molina, C. A., Foulkes, N. S., Lalli, E., Sassone-Corsi, P. (1993) Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75, 875-886.
53. Bodor, J., Bodorova, J., Gress, R. E. (2000) Suppression of T cell function: a potential role for transcriptional repressor ICER. J. Leukoc. Biol. 67, 774-779.
54. Garcia-Rodriguez, C., Rao, A. (1998) Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J. Exp. Med. 187, 2031-2036.
55. Masquilier, D., Sassone-Corsi, P. (1992) Transcriptional cross-talk: nuclear factors CREM and CREB bind to Ap-1 sites and inhibit activation by Jun. J. Biol. Chem. 267, 22460-22466.
56. Serfling, E., Chuvpilo, S., Liu, J., Hofer, T., Palmetshofer, A. (2006) NFATc1 autoregulation: a crucial step for cell-fate determination. Trends Immunol. 27, 461-469.
57. Bodor, J., Habener, J. F. (1998) Role of transcriptional repressor ICER in cyclic AMP-mediated attenutation of cytokine gene expression in human thymocytes. J. Biol. Chem. 273, 9544-9551.
58. Macian, F. (2005) NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472-484.
59. Gewinner, C., Hart, G., Zachara, N., Cole, R., Beisenherz-Huss, C., Groner, B. (2004) The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J. Biol. Chem. 279, 3563-3572.
60. Pouponnot, C., Jayaraman, L., Massague, J. (1998) Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 273, 22865-22868.
61. Vo, N., Goodman, R. H. (2001) CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276, 13505-13508.
62. Ruchaud, S., Seite, P., Foulkes, N. S., Sassone-Corsi, P., Lanotte, M. (1997) The transcriptional repressor ICER and cAMP-induced programmed cell death. Oncogene 15, 827-836.
63. Schiller, M., Verrecchia, F., Mauviel, A. (2003) Cyclic adenosine 3′,5′-monophosphate-elevating agents inhibit transforming growth factor-β-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Oncogene 22, 8881-8890.
64. Silva-Santos, B., Pennington, D. J., Hayday, A. C. (2005) Lymphotoxin-mediated regulation of γδ cell differentiation by αβ T cell progenitors. Science 307, 925-928.
65. Marie, J. C., Liggitt, D., Rudensky, A. (2006) Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25, 441-454.
66. Ziegler, S. F. (2006) FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209-226.
67. Quezada, S. A., Bennett, K., Blazar, B. R., Rudensky, A. Y., Sakaguchi, S., Noelle, R. J. (2005) Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation. J. Immunol. 175, 771-779.
68. Kaufman, H. L., Deraffele, G., Mitcham, J., Moroziewicz, D., Cohen, S. M., Hurst-Wicker, K. S., Cheung, K., Lee, D. S., Divito, J., Voulo, M., Donovan, J., Dolan, K., Manson, K., Panicali, D., Wang, E., Horig, H., Marincola, F. M. (2005) Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J. Clin. Invest. 115, 1903-1912.
69. Cha-Molstad, H., Keller, D. M., Yochum, G. S., Impey, S., Goodman, R. H. (2004) Cell-type-specific binding of the transcription factor CREB to the cAMP-response element. Proc. Natl. Acad. Sci. USA 101, 13572-13577.
70. Muthusamy, N., Leiden, J. M. (1998) A protein kinase C-, Ras-, and RSK2-dependent signal transduction pathway activates the cAMP-responsive element-binding protein transcription factor following T cell receptor engagement. J. Biol. Chem. 273, 22841-22847.
71. Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., Benard, A., Van Landeghen, M., Buckner, J. H., Ziegler, S. F. (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J. Clin. Invest. 112, 1437-1443.
72. Bluestone, J. A., St Clair, E. W., Turka, L. A. (2006) CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24, 233-238.
73. Davidson, A., Diamond, B., Wofsy, D., Daikh, D. (2005) Block and tackle: CTLA4Ig takes on lupus. Lupus 14, 197-203.
74. Quezada, S. A., Peggs, K. S., Curran, M. A., Allison, J. P. (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J. Clin. Invest. 116, 1935-1945.
75. Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., Morton, K. E., Mavroukakis, S. A., Duray, P. H., Steinberg, S. M., Allison, J. P., Davis, T. A., Rosenberg, S. A. (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100, 8372-8377.
76. Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M., Onodera, M., Uchiyama, T., Fujii, S., Sakaguchi, S. (2004) Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1643-1656.
77. Wing, K., Larsson, P., Sandstrom, K., Lundin, S. B., Suri-Payer, E., Rudin, A. (2005) CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. Immunology 115, 516-525.
78. Takahata, Y., Nomura, A., Takada, H., Ohga, S., Furuno, K., Hikino, S., Nakayama, H., Sakaguchi, S., Hara, T. (2004) CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp. Hematol. 32, 622-629.
79. Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., Neurath, M. F. (2004) Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153.
80. Birebent, B., Lorho, R., Lechartier, H., de Guibert, S., Alizadeh, M., Vu, N., Beauplet, A., Robillard, N., Semana, G. (2004) Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34, 3485-3496.
81. Salvalaggio, P. R., Camirand, G., Ariyan, C. E., Deng, S., Rogozinski, L., Basadonna, G. P., Rothstein, D. M. (2006) Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo. J. Immunol. 176, 2292-2298.
82. Mamura, M., Lee, W., Sullivan, T. J., Felici, A., Sowers, A. L., Allison, J. P., Letterio, J. J. (2004) CD28 disruption exacerbates inflammation in TGF-β1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-β1. Blood 103, 4594-4601.